Non-invasive image-guided targeted drug delivery

Affiliations

Comment

Dieter Haemmerich. Lancet Oncol. 2018 Aug.

. 2018 Aug;19(8):1000-1001.

doi: 10.1016/S1470-2045(18)30419-4. Epub 2018 Jul 11.

¹ Medical University of South Carolina, Charleston, SC 29425, USA. Electronic address: haemmer@musc.edu.

No abstract available

Comment on

Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial.
Lyon PC, Gray MD, Mannaris C, Folkes LK, Stratford M, Campo L, Chung DYF, Scott S, Anderson M, Goldin R, Carlisle R, Wu F, Middleton MR, Gleeson FV, Coussios CC. Lyon PC, et al. Lancet Oncol. 2018 Aug;19(8):1027-1039. doi: 10.1016/S1470-2045(18)30332-2. Epub 2018 Jul 11. Lancet Oncol. 2018. PMID: 30001990 Free PMC article. Clinical Trial.